Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026

AMD vs AVDL: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

AVDL Captures Overall Composite Edge (62.9 BUY vs 62.6 BUY), While AMD Leads 5–1 on Growth & Valuation Pillars

AVDL Overall Winner 6-Pillar Tally: AMD 5 – 1 AVDL Matrix Metrics: AMD 5 – 5 AVDL

As of Nov 20, 2026, Avadel Pharmaceuticals plc Ordinary Share (AVDL) captures the overall head-to-head institutional edge over Advanced Micro Devices (AMD) on higher Unified Composite conviction (62.9/100 BUY vs. 62.6/100 BUY) after splitting the core matrix 5–5 (led by Valuation Multiples), while AMD wins 5–1 across the 6-pillar growth and valuation breakdown. AMD trades at $424.39 (24.1x Forward P/E, 17.8% operating margin) versus AVDL at $21.64 (28.8x Forward P/E, 2.5% operating margin).

  • Growth vs. Quality Trade-Off: AVDL earns the overall head-to-head edge with a stronger Unified Composite Score (62.9/100 BUY vs. AMD 62.6/100 BUY) and 0.14β · 2% Vol risk profile, whereas AMD leads top-line expansion (+44.7% YoY revenue growth, 0.47x PEG, and 5 of 6 institutional pillars) for higher-beta growth mandates.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About AMD vs AVDL
AMD NASDAQ
Advanced Micro Devices
Semiconductors & Related Devices
$424.39
-13.25% 1D
Market Cap $809.6B
TTM Revenue $45.4B
Forward P/E 24.1x
Beta / 30D Vol 3.65β · 124% Vol
Unified Composite Score
62.6 / 100 BUY
Tech 50.0 Fund 60.0 Flow 67.0 Mom 64.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 38
RSI-14: 38.4 · SMA20: $509.08 · SMA50: $553.10
AVDL NASDAQ Head-to-Head Winner
Avadel Pharmaceuticals plc Ordinary Share
Pharmaceutical Preparations
$21.64
+0.05% 1D
Market Cap $2.1B
TTM Revenue $249M
Forward P/E 28.8x
Beta / 30D Vol 0.14β · 2% Vol
Unified Composite Score
62.9 / 100 BUY
Tech 75.0 Fund 60.0 Flow 50.0 Mom 50.0
Weinstein Technical Phase Markup · Hold / add on dips
Price above SMA50, rising 50-day trend (1.4% over 20 days), RSI 62
RSI-14: 62.3 · SMA20: $21.56 · SMA50: $21.50

6-Pillar Scorecard Institutional Category Breakdown (AMD 5 – 1 AVDL)

Columns: Metric · AMD · AVDL
1. Valuation Multiples AVDL
Forward P/E 24.1x 28.8x
Trailing P/E 104.5x 16.8x
PEG Ratio 0.47x 0.07x
EV / Revenue 17.9x 8.5x
2. Growth & Scale AMD
Revenue Growth (YoY) +44.7% +54.9%
Earnings Growth (YoY) +93.8% +0.0%
TTM Revenue (USD) $45.4B $249M
Market Cap $809.6B $2.1B
3. Profitability & Quality AMD
Gross Margin 56.0% 94.9%
Operating Margin 17.8% 2.5%
Net Profit Margin 16.8% -0.1%
Return on Equity (ROE) 12.0% -0.3%
4. Balance Sheet & Cash Flow AMD
Cash Generation (TTM) $7.06B $2.7M EBITDA
Cash Flow Margin 15.5% 1.1% EBITDA Mgn
Net Cash / Leverage $1.51B Net Debt (0.13x D/E) $1.01 Book/Sh · -0.3% ROE
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning AMD
Options Structure Phase CONSOLIDATION UNCLASSIFIED
Current IV / %ile 87.2% (11th %ile) 2.4% (<1st %ile)
Put/Call OI Skew 1.31x (Put-Skewed) N/A
OBV Trend / Tech Phase DISTRIBUTION · Neutral NEUTRAL · Markup
6. R&D & Supply-Chain Moat AMD
OpEx & R&D Intensity 38.2% of Rev ($17.4B) N/A
90D R&D Disclosures 7 papers 0 papers
Competitive Moat Concentrated Oligopoly Moat Cyclical / Execution-Driven Positioning
Supply-Chain Role AI Accelerator & Server Chiplet Designer Drug Manufacturers - Specialty & Generic Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: AMD (5) vs AVDL (5)
Institutional Metric AMD AVDL Criterion Row Edge
Market Capitalization
Scale
$809.6B $2.1B Larger Scale AMD
Trailing P/E Ratio
Valuation
104.5x 16.8x Lower Multiple AVDL
Forward P/E Ratio
Valuation
24.1x 28.8x Lower Multiple AMD
Revenue Growth (YoY)
Growth
+44.7% +54.9% Higher Growth AVDL
Operating Margin (TTM)
Profitability
17.8% 2.5% Higher Margin AMD
Net Profit Margin
Profitability
16.8% -0.1% Higher Margin AMD
Return on Equity (ROE)
Capital Efficiency
12.0% -0.3% Higher ROE AMD
52-Week Range Position
Momentum
50% ($188–$659) 89% ($6–$24) Stronger Trend AVDL
Beta / 30D Volatility
Risk Regime
3.65β · 124% Vol 0.14β · 2% Vol Lower Realized Risk AVDL
Unified Institutional Score
Composite Signal
62.6 / 100 (BUY) 62.9 / 100 (BUY) Higher Composite AVDL
Trailing 12M Revenue (USD)
Operating Scale
$45.4B $249M FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
56.0% 94.9% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
0.47x PEG · 17.9x EV/Rev 0.07x PEG · 8.5x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
$7.06B ($1.51B Net Debt (0.13x D/E)) $2.7M EBITDA ($1.01 Book/Sh · -0.3% ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon AMD +2.19 pp
AMD: +2.84% · AVDL: +0.65%
3M Horizon AMD +1.86 pp
AMD: -4.46% · AVDL: -6.32%
6M Horizon AMD +1.86 pp
AMD: -4.46% · AVDL: -6.32%
1Y Horizon AMD +1.86 pp
AMD: -4.46% · AVDL: -6.32%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on AMD vs AVDL. Trailing 12-month operating profitability (AMD 17.8% vs AVDL 2.5%) and valuation multiples (AMD 24.1x vs AVDL 28.8x Forward P/E) are benchmarked directly in Pillar 4 below.

AMD ADR TTM Benchmark FX-Normalized USD
TTM Revenue$45.4B
Gross Margin56.0%
Op. Margin17.8%
ROE / Fwd P/E12.0% · 24.1x
AVDL ADR TTM Benchmark FX-Normalized USD
TTM Revenue$249M
Gross Margin94.9%
Op. Margin2.5%
ROE / Fwd P/E-0.3% · 28.8x

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
AMD CONSOLIDATION
107d in phase · OBV DISTRIBUTION
Current IV 87.2%
IV Percentile 11th %ile
Put/Call OI Skew 1.31x (Put-Skewed)
IV Regime Compressed (<25th %ile)
Put Wall Floor $430.00
Call Wall Magnet $500.00
Net Delta Signal NEUTRAL
OBV Flow DISTRIBUTION
Put Floor: $430.00 (1.3%) Spot: $424.39 Call Magnet: $500.00 (+17.8%)
  • Extended consolidation (107 days)
  • IV expanding (+13.7%) but put wall rising - pre-earnings positioning (neutral)
  • Near put wall support ($430)
AVDL UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV 2.4%
IV Percentile <1st %ile
Put/Call OI Skew N/A
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact AVDL Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
LIVE OPTIONS CHAIN · T+5 TRADING DAY HORIZON Spot $504.28 · IV 73.5%

AMD Simulated 5-Day Option Payoffs vs. Owning 100 Shares ($50,428)

Compare $50,428 in 100-share capital outlay against risk-defined 5-day vertical spreads, put-wall income, and 3-leg structures at 73.5% ATM IV.

5-DAY BULLISH SWING Liq A

Dec 18 $510 / $580 Bull Call Spread

Buy 1x $510C · Sell 1x $580C · 31d

Net Entry $2,436 Debit
T+5d @ +5% Move +$583 (+24%)
Max Risk / Buffer $2,436 Capped
5d Edge & Liquidity 0.7x R:R · Liq A
Simulate 5-Day Payoff →
PUT-WALL MONTHLY INCOME Liq A

Dec 18 $440 / $410 Bull Put Spread

Sell 1x $440P · Buy 1x $410P · 31d

Net Entry $731 Credit
Max Credit / Yield +$731 (+32.2% RoM)
Max Risk / Buffer -14.2% Cushion ($2,269 Mgn)
5d Edge & Liquidity 76% PoP · Liq A
Simulate 5-Day Payoff →
ASYMMETRIC 3-LEG STRUCTURE Liq A

Dec 18 $450P / $520-$590C Seagull

Sell 1x $450P · Buy 1x $520/$590C · 31d

Net Entry $52 Debit
T+5d @ +5% Move +$1,463 (+21.3% RoM)
Max Risk / Buffer -10.8% Put Cushion ($6,861 Mgn)
5d Edge & Liquidity 1.0x R:R · Liq A
Simulate 5-Day Payoff →

Simulated T+5 trading day payoffs use live option midpoints, bid-ask spread adjustments, and implied volatility skew for educational scenario modeling only — not personalized investment advice. Options involve substantial risk.

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
AMD Moat Profile Concentrated Oligopoly Moat
AI Accelerator & Server Chiplet Designer
Data center GPU accelerators and server CPU chiplets scale directly with upstream leading-edge foundry utilization and cloud server integration.
OpEx & R&D Reinvestment 38.2% of Rev ($17.4B)
90D Engineering Disclosures 7 Published · LLM Efficiency / Architecture
Mapped Supply-Chain Ecosystem (18 partners):
Taiwan Semiconductor Manufacturing Company GlobalFoundries Samsung Electronics ASE Technology Holding
Active 90D Technical Topics:
Edge AI / Inference Chips Hardware-Agnostic ML Compilers Inference Serving / Speculative Decoding KV-Cache / Attention Memory Compression Mixture-of-Experts / Sparse Models
AVDL Moat Profile Cyclical / Execution-Driven Positioning
Drug Manufacturers - Specialty & Generic Operator
Competes within the Drug Manufacturers - Specialty & Generic value chain with $2.1B market capitalization and 2.5% operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published

Investor FAQ AMD vs AVDL Key Questions & Quantitative Answers

As of Nov 20, 2026, Avadel Pharmaceuticals plc Ordinary Share (AVDL) captures the overall head-to-head institutional edge over Advanced Micro Devices (AMD) on higher Unified Composite conviction (62.9/100 BUY vs. 62.6/100 BUY) after splitting the core matrix 5–5 (led by Valuation Multiples), while AMD wins 5–1 across the 6-pillar growth and valuation breakdown. AMD trades at $424.39 (24.1x Forward P/E, 17.8% operating margin) versus AVDL at $21.64 (28.8x Forward P/E, 2.5% operating margin). Growth vs. Quality Trade-Off: AVDL earns the overall head-to-head edge with a stronger Unified Composite Score (62.9/100 BUY vs. AMD 62.6/100 BUY) and 0.14β · 2% Vol risk profile, whereas AMD leads top-line expansion (+44.7% YoY revenue growth, 0.47x PEG, and 5 of 6 institutional pillars) for higher-beta growth mandates.

AMD leads the Growth & Scale pillar: AMD posts +44.7% YoY revenue growth and +93.8% YoY earnings growth on $45.4B TTM revenue (56.0% gross margin, 17.8% operating margin), compared with AVDL at +54.9% YoY revenue growth and +0.0% YoY earnings growth on $249M TTM revenue (94.9% gross margin, 2.5% operating margin). On trailing 12-month operating scale, AMD generates $45.4B in USD-normalized revenue versus $249M for AVDL. In operating R&D and SG&A reinvestment, AMD deploys 38.2% of Rev ($17.4B) (7 90-day corporate R&D disclosures) versus N/A (0 disclosures) for AVDL.

AVDL screens cheaper on headline valuation multiples. AMD trades at 24.1x Forward P/E, 104.5x Trailing P/E, 0.47x PEG, and 17.9x EV/Revenue (15.5% FCF margin), whereas AVDL trades at 28.8x Forward P/E, 16.8x Trailing P/E, 0.07x PEG, and 8.5x EV/Revenue (1.1% EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against AMD (12.0% ROE) versus AVDL (-0.3% ROE) capital efficiency.

In options market volatility and institutional positioning, AMD carries 87.2% implied volatility (11th %ile, Compressed (<25th %ile)), a 1.31x (Put-Skewed) Put/Call open-interest ratio, DISTRIBUTION on-balance volume, and sits in a CONSOLIDATION options structure phase (3.65β · 124% Vol realized risk). By comparison, AVDL carries 2.4% implied volatility (<1st %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.14β · 2% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 20, 2026. For educational research only; not investment advice.